Y-mAbs Therapeutics A/S — Credit Rating and Financial Key Figures
CVR number: 37053678
Agern Alle 11, 2970 Hørsholm
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | 52 032.45 | 82 433.52 | 67 549.57 | 82 332.36 | 70 656.04 |
Employee benefit expenses | -46 918.26 | -75 828.30 | - 105 682.44 | - 128 511.47 | -90 964.90 |
Other operating expenses | - 158.64 | - 226.71 | |||
Total depreciation | -1 347.78 | -1 582.71 | -2 081.97 | -30 492.19 | - 806.29 |
EBIT | 3 766.40 | 5 022.51 | -40 214.84 | -76 829.95 | -20 888.43 |
Other financial income | 1 631.28 | 0.29 | 20.03 | ||
Other financial expenses | -6 345.80 | -6 224.93 | -3 504.20 | -8 856.17 | -6 880.44 |
Pre-tax profit | -2 579.40 | -1 202.42 | -42 087.77 | -85 685.82 | -27 748.84 |
Net earnings | -2 579.40 | -1 202.42 | -42 087.77 | -85 685.82 | -27 748.84 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Intangible rights | 27 181.09 | 27 181.09 | 68.33 | 68.33 | |
Intangible assets total | 27 181.09 | 27 181.09 | 68.33 | 68.33 | |
Land and waters | 3 129.34 | 1 916.94 | 11 297.80 | 8 624.53 | 4 911.77 |
Machinery and equipment | 1 199.43 | 1 665.11 | 2 170.86 | 1 296.35 | 490.06 |
Tangible assets total | 4 328.78 | 3 582.04 | 13 468.66 | 9 920.89 | 5 401.83 |
Investments total | 761.37 | 793.96 | 1 886.06 | 1 885.98 | 1 793.01 |
Long term receivables total | |||||
Inventories total | |||||
Current trade debtors | 39 345.80 | ||||
Prepayments and accrued income | 880.94 | 1 510.09 | 1 858.19 | 1 943.35 | 2 764.82 |
Current other receivables | 7 421.34 | 9 492.38 | 8 737.92 | 6 907.90 | 6 338.34 |
Short term receivables total | 8 302.29 | 11 002.47 | 10 596.11 | 8 851.25 | 48 448.96 |
Cash and bank deposits | 22 344.01 | 9 478.11 | 8 340.00 | 2 179.33 | 946.25 |
Cash and cash equivalents | 22 344.01 | 9 478.11 | 8 340.00 | 2 179.33 | 946.25 |
Balance sheet total (assets) | 35 736.44 | 52 037.67 | 61 471.93 | 22 905.76 | 56 658.38 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Share capital | 3 166.67 | 3 166.67 | 3 166.67 | 9 833.33 | 9 833.33 |
Share premium account | 10 833.33 | 10 833.33 | 10 833.33 | 44 166.66 | 44 166.66 |
Retained earnings | -7 385.52 | -9 964.92 | -11 167.34 | -53 255.11 | - 138 940.93 |
Profit of the financial year | -2 579.40 | -1 202.42 | -42 087.77 | -85 685.82 | -27 748.84 |
Shareholders equity total | 4 035.07 | 2 832.66 | -39 255.11 | -84 940.94 | - 112 689.78 |
Provisions | 84 559.93 | 151 203.21 | |||
Non-current leasing loans | 2 086.67 | 733.97 | 2 673.26 | 5 811.14 | 2 437.80 |
Non-current other liabilities | 1 612.32 | 5 596.56 | 5 705.32 | ||
Non-current deferred tax liabilities | 5 789.22 | 5 826.52 | |||
Non-current liabilities total | 3 698.99 | 6 330.53 | 8 378.58 | 11 600.36 | 8 264.32 |
Current trade creditors | 15 174.18 | 15 156.69 | 13 359.24 | 16 311.44 | |
Current owed to group member | 8 117.74 | 16 140.38 | 60 352.58 | 68 447.62 | 132 349.52 |
Other non-interest bearing current liabilities | 4 710.46 | 26 734.10 | 16 839.19 | -70 120.44 | - 138 780.33 |
Current liabilities total | 28 002.37 | 42 874.48 | 92 348.46 | 11 686.42 | 9 880.63 |
Balance sheet total (liabilities) | 35 736.44 | 52 037.67 | 61 471.93 | 22 905.76 | 56 658.38 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.